Research

Translating research
evidence into practice

Research

PUBLICATION:

  • Flatt AJS, Little SA, Speight J, Leelarathna L, Walkinshaw E, Kai Tan H, Bowes A, Lubina-Solomon A, Holmes-Truscott E, Chadwick TJ, Wood R, McDonald TJ, Kerr D, Flanagan D, Brooks A, Heller SR, Evans ML and Shaw JAM. Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study. Diabetes Care 2020 Jan; 43(1): 44-52
  • Speight J, Holmes-Truscott E, Little SA, Leelarathna L, Walkinshaw E, Tan HK, Bowes A, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JAM. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial. 

Diabetes Technol Ther 2019 Nov; 21(11):619-626

  • Little SA, Speight J, Leelarathna L, Walkinshaw E, Kai Tan H, Bowes A, Lubina-Solomon A, Chadwick T, Stocken D, Brennand C, Marshall1 SM, Wood R, Kerr D, Flanagan D, Heller SR, Evans ML and Shaw JAM. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial. Diabetes Care 2018 Aug; 41(8): 1600-1607.
  • Everett J, Bowes A & Kerr D. Barriers to improving glycaemia control with insulin pump therapy. Journal of Diabetes Nursing, Vol 14, No5, 2010.
  • Bowes A, Begley J, Kerr D. Lifestyle change reduces cardiometabolic risk factors and glucagon-like peptide-1 levels in obese first-degree relatives of people with diabetes. Journal of Human Nutrition and Dietetics. 2017 Feb.
  • Bowes A, Payne R, Jenkinson R, Kerr D. Translating research evidence into practice: A community-based lifestyle programme for the prevention of type 2 diabetes. British Journal of Obesity, Vol 1, No 4, Pages 124–167
  • Begley J, Bowes A, Heart T, Kerr D. Metabolic impact of a successful lifestyle intervention in patients with new onset type 2 diabetes; a pilot study. Journal of Diabetes Research and Clinical Metabolism, 2013.

ORAL, POSRET PRESENTATIONS and Workshops at the National and International Conferences:

  • Oral presentation and nomination for the “Educational Award”, Diabetes UK conference, Glasgow, UK, Mar 2009: Bowes A & Kerr D “The effectiveness of a mobile phone based approach for teaching carbohydrate counting in comparison to a standard programme in Type 1 diabetes” Royal Bournemouth Hospital, UK
  • Poster presentation at the American Diabetes Association 73rd Congress, Chicago, June 2013: Bowes A, Hale A, Haviland J & Kerr D “Increase in weight but no improvement in glycaemic control over a decade in patients living with type 1 diabetes mellitus”. Royal Bournemouth Hospital, UK
  • Poster presentation at the Diabetes UK, Manchester, UK, Apr 2013:

Bowes A, Hale A, Haviland J & Kerr D “Obesity trends in people with type 1 diabetes are the same as for the general UK population” Royal Bournemouth Hospital, UK

  • Poster presentation at the Diabetes UK conference, London, UK, Apr 2011:

Bowes A, Partridge H, Knott J & Kerr D “Initiating insulin pump therapy – most of the HbA1c benefit is within the first 6 months.”

  • Workshops for Health Care Professionals at the “Insulin Pump Summit”, Birmingham, UK, Apr 2010. Bowes A “Developing a local pump service”.
  • Oral presentation at the Diabetes UK 2014 , Liverpoole, Abbott symposium to launch Libre sensor “Ambulatory Glucose Monitoring Case Studies/ Retrospective Database Analysis”
  • Poster presentation at the Diabetes UK conference, Liverpool, UK, Mar 2010:

Everett J, Bowes A, Humprey R & Kerr D “Barriers to improving glycaemia control with insulin pump therapy”. 

  • On-line video educational material to help people with type 1 diabetes setting basal and bolus rates “Diabetes Moments”; patient education video material for Roche Expert meter and Combo insulin pump settings.
  • Oral presentation at the 6th World Congress of Prevention of Diabetes and its Complications, Dresden, Germany, Apr 2010:

Bowes A, Begley J, Heart T & Kerr D “The sustained reversal of type 2 diabetes by intensive lifestyle intervention at diagnosis”. Royal Bournemouth Hospital, UK

  • Oral presentation at the 69th American Diabetes Association conference, New Orleans, USA, Jun 2009:

Bowes A, Begley J Heart T, Painter H, & Kerr D “Effect of Intensive Lifestyle Intervention on Glucagon Like Peptide-1 (GLP-1) Levels in Patients with New Onset Type 2 Diabetes.” Royal Bournemouth Hospital, UK

  • Oral and poster presentation at Diabetes UK 2015 conference:

A Bowes, D Kerr, A Koveraite, J Walker, S Perring, EL Jones, J Begley “Impact of a successful cost effective 8-month lifestyle intervention in obese first-degree relatives of people with diabetes” Royal Bournemouth Hospital, UK

  • Poster Presentation at the Diabetes UK 2016 conference & (QIC) award:

Bowes A, Masding M, Sherlock S “Nurse and Dietitian led structured group education programme for people with new onset type 2 diabetes provides platform to improve glycaemic control and manage weight as soon as possible after diagnosis” Poole Hospital, UK.

  • Poster presentation and at the Diabetes UK 2018 & QIC award:

A Bowes*, S Sherlock, S Whittle, J Walker, N Stacey

““RE-FOCUS on your diabetes” A county wide pilot self-management group education programme for people with Type 2 diabetes with suboptimal glycaemic control shows reduction in glycaemia and diabetes-related emotional distress” Poole Hospital, UK.

  • Abstract presentation at the Diabetes UK 2020 (on-line)

Bowes, J Beeson, M Conde, K Thomas & M G Masding “Dietitian-led care is safe & effective in women with Gestational Diabetes Mellitus. The Dietitian-led secondary care multidisciplinary Gestational Diabetes Service evaluation 2018 audit.” Poole Hospital, UK. 

  • Dietetic expert for the on-line educational material delivery “Byetta By Your Side” Lilly UK.
  • Poster presentation at the Diabetes UK conference, Glasgow, UK, 2012 

Bowes A, Field V, Haviland J and  Kerr D  “Exenatide treatment with insulin has less improvement in glycaemic control than without insulin but the same reduction in weight.” Royal Bournemouth Hospital, UK